A Multiple Myeloma Trial in Patients With Bone Metastases

Clinical trial NCT00104104 · COMPLETED

Trial details

NCT number: NCT00104104
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2004-10-01
Primary completion: 2007-10-01
Enrollment: 179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.